Actively Recruiting

All Genders
NCT02745158

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Led by The International FOP Association · Updated on 2026-04-08

800

Participants Needed

1

Research Sites

1330 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. A physician portal (in development) will allow physicians to enter clinical data about their patients. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.

CONDITIONS

Official Title

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have a confirmed diagnosis of FOP.
  • Participants (or a parent or legal guardian) must be willing and able to provide written informed consent.
Not Eligible

You will not qualify if you...

  • There are no exclusion criteria.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The International Fibrodysplasia Ossificans Progressiva Association (IFOPA)

North Kansas City, Missouri, United States, 064116

Actively Recruiting

Loading map...

Research Team

M

Mark S Hamilton, PhD

CONTACT

S

Sammi Kile, MS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here